The prognostic potential of KDM6B was validated in a cohort of HNSCC patients who received post-operative radio/chemotherapy (n = 187, DKTK-ROG cohort, [9]) (Supplementary Table S1). This evidence concerns the gene KDM6B and head and neck squamous cell carcinoma.